Divi’s Laboratories Ltd.’s quarterly profit rose by nearly 7% sequentially, beating analyst forecasts.
India’s second-largest drugmaker by market value reported a net profit of Rs 502.02 crore in the three months through March, according to its exchange filing. Analysts’ estimates compiled by Bloomberg pegged a profit of Rs 469.94 crore.
Revenue rose 5% quarter-on-quarter to Rs 1,788.19 crore—the consensus estimate was Rs 1,700.48 crore.
Divi’s Labs Q4 Results: Net Profit Rises 7%, Beats Estimates - BloombergQuint
Read More
No comments:
Post a Comment